Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
IsoPlexis revenue
IsoPlexis's revenue is $16.8 million.
What is IsoPlexis's revenue?
- IsoPlexis's revenue growth from 2020 to 2022 is 61.37%.
- IsoPlexis has 200 employees, and the revenue per employee ratio is $83,805.
- IsoPlexis's peak quarterly revenue was $5.5M in 2021(q4).
- IsoPlexis peak revenue was $17.3M in 2021.
- IsoPlexis annual revenue for 2021 was 17.3M, 66.15% growth from 2020.
- IsoPlexis annual revenue for 2022 was 16.8M, -2.88% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
IsoPlexis historical revenue
IsoPlexis's peak revenue was $17.3M in 2021. The peak quarterly revenue was $5.5M in 2021(q4).
IsoPlexis's revenue increased from $10.4m in 2020 to $16.8M currently. That's a 61.37% change in annual revenue.
IsoPlexis annual revenue
IsoPlexis annual revenue over time
| Fiscal year / year | IsoPlexis revenue |
|---|---|
| 2020 | $10.4M |
| 2021 | $17.3M |
| 2022 | $16.8M |
IsoPlexis jobs nearby
Do you work at IsoPlexis?
Did IsoPlexis meet its revenue projections?
IsoPlexis financing
IsoPlexis received early financing of $100.0K on 2014-06-05.
| Series | Round size | Date |
|---|---|---|
| Seed | $100K | 06/2014 |
| Seed | $300K | 08/2014 |
| Series A | $1.3M | 08/2014 |
| Series Unknown | $2.4M | 05/2015 |
| Series B | $13.5M | 09/2017 |
| Series C | $25M | 05/2019 |
| Grant | $4M | 06/2019 |
| Grant | $2M | 10/2019 |
| Series C | $20M | 01/2020 |
| Grant | $2M | 06/2020 |
| Series D | $85M | 01/2021 |
| Debt Financing | $50M | 01/2021 |
IsoPlexis investors
| Investors | Security type |
|---|---|
| Connecticut Innovations | Seed |
| YEI Innovation Fund | Seed |
| Connecticut Innovations | Seed |
| Spring Mountain Capital | Series A |
| Connecticut Innovations | Series A |
| Spring Mountain Capital | Series B |
| Connecticut Innovations | Series B |
| North Sound Ventures | Series B |
| Ironwood Capital | Series B |
| Spring Mountain Capital | Series C |
| Connecticut Innovations | Series C |
| North Sound Capital | Series C |
| Ironwood Capital | Series C |
| Northpond Ventures | Series C |
| National Cancer Institute SBIR Development Center | Grant |
| National Cancer Institute SBIR Development Center | Grant |
| Spring Mountain Capital | Series C |
| Connecticut Innovations | Series C |
| North Sound Capital | Series C |
| Ironwood Capital | Series C |
| Northpond Ventures | Series C |
| National Institute on Aging | Grant |
| Ally Bridge Group | Series D |
| Perceptive Advisors | Series D |
| BlackRock, Inc. | Series D |
| Ally Bridge Group | Debt Financing |
| Perceptive Advisors | Debt Financing |
| BlackRock, Inc. | Debt Financing |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of IsoPlexis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about IsoPlexis. The employee data is based on information from people who have self-reported their past or current employments at IsoPlexis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by IsoPlexis. The data presented on this page does not represent the view of IsoPlexis and its employees or that of Zippia.
IsoPlexis may also be known as or be related to IsoPlexis, IsoPlexis Corp, IsoPlexis Corp., IsoPlexis Corporation and Isoplexis.